Sharad K. Verma

4.5k citations
27 papers · 400 indexed · h-index 12
Topics
Neurofibromatosis and Schwannoma Cases (8 papers)Epigenetics and DNA Methylation (6 papers)Cancer-related gene regulation (6 papers)

In The Last Decade

Sharad K. Verma

27 papers receiving 391 citations

Peers

Sharad K. Verma
Comparison fields: 5 of 63
  • Neurology 159
  • Molecular Biology 144
  • Organic Chemistry 95
  • Rheumatology 66
  • Pulmonary and Respiratory Medicine 62
Replace Eric Shi with:
Eric Shi United States
Guolin Chai China
Anna Kohlmann United States
Emily R. Theisen United States
Dae Hwa Choi South Korea
Kouichi Tokuda Japan
Robert M. Sutphin United States
Hideko Murooka Japan
Dong-Jun Lin China
Ruoxuan Hei China
Sharad K. Verma relative to Eric Shi United States Eric Shi's profile →
Citations per field
00.5×10×15×20.5×
Eric Shi · 1×
Citations per year

Countries citing papers authored by Sharad K. Verma

Since Specialization
Citations

This map shows the geographic impact of Sharad K. Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharad K. Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharad K. Verma more than expected).

Fields of papers citing papers by Sharad K. Verma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharad K. Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharad K. Verma. The network helps show where Sharad K. Verma may publish in the future.

Co-authorship network of co-authors of Sharad K. Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Sharad K. Verma. A scholar is included among the top collaborators of Sharad K. Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharad K. Verma. Sharad K. Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 4
4 11
5 4
6 23
7 26
8 7
9 72
10 7
11 3
12 35
13 8
14 2
15 8
16 12
17 6
18 14
19 1
20 21

About Sharad K. Verma

Sharad K. Verma is a scholar working on Neurology, Rheumatology and Organic Chemistry, having authored 27 papers that have together received 400 indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (8 papers), Epigenetics and DNA Methylation (6 papers) and Cancer-related gene regulation (6 papers). The work is most often cited by research in Neurology (159 citations), Rheumatology (66 citations) and Organic Chemistry (95 citations). Sharad K. Verma has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Harold W. Moore, Jaishri O. Blakeley, Vincent M. Riccardi, James M. MacDougall, Everly B. Fleischer, P. Wolkenstein, Abha Mishra, Philip Turnbull, Scott R. Plotkin and Steven D. Knight. Their work appears in journals such as Neurology, JNCI Journal of the National Cancer Institute and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026